Cigna Group $CI Position Reduced by Focused Investors LLC

Focused Investors LLC lessened its holdings in Cigna Group (NYSE:CI) by 2.1% during the second quarter, Holdings Channel.com reports. The firm owned 559,750 shares of the health services provider’s stock after selling 11,900 shares during the quarter. Cigna Group accounts for 6.1% of Focused Investors LLC’s investment portfolio, making the stock its 5th largest holding. Focused Investors LLC’s holdings in Cigna Group were worth $185,042,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of CI. Valeo Financial Advisors LLC increased its position in shares of Cigna Group by 86,071.1% in the second quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after acquiring an additional 3,471,249 shares during the period. Nuveen LLC purchased a new position in shares of Cigna Group in the first quarter valued at about $727,905,000. Price T Rowe Associates Inc. MD increased its position in shares of Cigna Group by 10.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after acquiring an additional 1,094,327 shares during the period. GQG Partners LLC boosted its stake in shares of Cigna Group by 21.5% during the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after purchasing an additional 865,092 shares in the last quarter. Finally, Goldman Sachs Group Inc. boosted its stake in shares of Cigna Group by 38.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock valued at $542,796,000 after purchasing an additional 457,052 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Up 1.4%

CI opened at $307.21 on Wednesday. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The firm has a 50 day moving average price of $292.94 and a 200-day moving average price of $309.54. Cigna Group has a twelve month low of $256.89 and a twelve month high of $358.88. The stock has a market capitalization of $82.00 billion, a price-to-earnings ratio of 16.77, a PEG ratio of 0.89 and a beta of 0.45.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, beating the consensus estimate of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm had revenue of $67.13 billion during the quarter, compared to analysts’ expectations of $62.61 billion. During the same period in the previous year, the company earned $6.72 earnings per share. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities research analysts forecast that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were issued a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date of this dividend was Thursday, September 4th. Cigna Group’s dividend payout ratio is currently 32.97%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Cigna Group in a research note on Saturday, September 27th. Robert W. Baird set a $372.00 target price on shares of Cigna Group in a research note on Thursday, August 14th. Truist Financial set a $375.00 target price on shares of Cigna Group in a research note on Tuesday, September 2nd. Barclays lifted their target price on shares of Cigna Group from $354.00 to $383.00 and gave the company an “overweight” rating in a research note on Thursday, September 4th. Finally, TD Cowen raised shares of Cigna Group to a “strong-buy” rating in a research note on Monday, June 23rd. Two analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, Cigna Group has an average rating of “Moderate Buy” and a consensus target price of $372.69.

Insider Buying and Selling

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the sale, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. This represents a 9.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Nicole S. Jones sold 28,526 shares of the company’s stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.70% of the stock is currently owned by corporate insiders.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.